LTR Pharma LimitedASX: LTP

Appendix 4G and Corporate Governance Statement

· Issued by LTR Pharma Limited via ASX

Filed with ASX ·

LTR Pharma Limited – 2026 Corporate Governance Statement LTR Pharma Limited ACN 644 924 569 Corporate governance statement This statement was approved by the Board on 28 August 2026 Overview As an ASX listed company, LTR Pharma Limited ACN 103 087 449 ( LTR Pharma or...

View Attachment

6ix hasn’t read this filing yet.

LTR Pharma Limited on 6ix

Earlier from LTR Pharma

Later from LTR Pharma

All LTR Pharma news releases